Newsletter Edition 80
Aug 14, 2025
PE-Backed Aland Health Prepares for $1.5 Billion Sale
Aland Health Holding, a global nutritional supplements manufacturer, is exploring a potential sale valued at more than $1.5 billion, according to a report by Reuters.
The company’s ownership is split between Founder and Chairman Chang Liang, who controls roughly 60%, and a group of private equity and growth investors including Affinity Equity Partners and Goldman Sachs Capital Partners. The process remains in its early stages, but has reportedly attracted interest from both strategic buyers and private equity firms.Aland is projected to deliver around $150 million in EBITDA in 2025. Its US subsidiary, International Vitamin Corporation (IVC), is viewed as a major draw for potential bidders seeking domestic production capabilities and exposure to the fast-growing wellness market.
The global nutritional supplements sector, valued at $485.6 billion in 2024, is expected to expand at a 6.4% CAGR, reaching $704.3 billion by 2030.
Founded in 1998, Aland operates 11 manufacturing sites and four R&D centers across Asia, North America, and Europe. The company supplies both branded and private-label products to major retailers including Walmart and Costco.
https://www.privateequitywire.co.uk/pe-backed-aland-health-targets-1-5bn-sale/
Advent to Acquire Insurance Software Provider Sapiens in $2.5 Billion All-Cash Deal
Advent International has agreed to acquire Sapiens International Corporation, a global provider of SaaS-based insurance software, in an all-cash transaction valuing the company at approximately $2.5 billion.
Under the terms of the deal, Sapiens shareholders will receive $43.50 per share, representing a 64% premium to the company’s unaffected share price prior to the announcement. Existing shareholder Formula Systems will retain a minority stake once the transaction closes.
The acquisition, which has received unanimous approval from Sapiens’ board, is expected to close in Q4 2025 or early 2026, subject to regulatory and shareholder approvals. Upon completion, Sapiens will become a private company.
Advent plans to use its operational expertise and capital resources to accelerate Sapiens’ innovation in cloud-based and AI-driven insurance solutions, including SaaS products serving life, pension, annuities, and property & casualty markets. The partnership aims to expand Sapiens’ global reach and speed up product development, helping insurers modernize their operations.
Sapiens currently serves more than 600 clients worldwide and employs approximately 2,800 people. Carlyle, a previous investor, will fully exit its stake as part of the transaction.
William Blair & Company served as financial advisor to Sapiens, while Citi advised Advent on the deal.
https://www.reinsurancene.ws/advent-to-acquire-sapiens-for-2-5bn/
TPG Closes $4.8 Billion Growth Fund Above Target
TPG has closed its latest growth equity fund, TPG Growth VI, at $4.8 billion, surpassing its $4 billion target on the back of strong demand from both existing limited partners and new investors across the Middle East, Asia, and Latin America, Bloomberg reports.
The fundraise, completed in just under two years, continues TPG’s growth equity strategy launched in 2007, which targets high-growth companies in software, enterprise technology, internet and digital media, healthcare, and business services.
Despite a challenging exit environment for many private equity managers, TPG has already deployed around 40% of the fund across 10 investments, including Schott Pharma, Cliffwater, and K2 Medical Research. As of 30 June, TPG Growth managed $20.2 billion in assets under management (AUM) and had signed or closed $2.3 billion in exits this year, maintaining an approximate 2:1 ratio of realizations to new investments.
Co-managing partners David Trujillo and Matt Hobart said the strategy seeks companies capable of delivering 20–30% annual growth, using either control positions or significant minority stakes of at least 20% to ensure governance influence. Trujillo noted that TPG avoided overexposure to unprofitable tech companies during the 2020–21 investment boom, while Hobart emphasized the importance of sector and theme selection over macroeconomic timing.
Select transactions from the fund will also be syndicated through TPG Private Equity Opportunities, the firm’s co-investment platform for high-net-worth investors. Parent company TPG, which oversaw $261 billion in AUM at the end of June, reported a 30% year-on-year rise in Q2 after-tax distributable earnings to $268.3 million.